Sponsor:
SurgiQuest, Inc.
Code:
NCT04165525
Conditions
Mastectomy; Lymphedema
Eligibility Criteria
Sex: Female
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Ablation
Brief summary:
Conditions
Mastectomy; Lymphedema
Study ID
NCT04165525
Start date
May 26, 2021
Status verified date
May, 2021
Completion date
Dec 30, 2022
Anticipated
Primary completion date
Jun 30, 2022
Anticipated
Eligibility Criteria
Sex: Female
Age: 18 - 70+
Healthy Volunteers: Not accepted
Enrollment
82 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
active comparator: HelixAR Electrosurgical Generator (HEG)
active comparator: Conventional Electrosurgical Coagulation (CEC) Systems
Interventions
Ablation
Primary outcome measure
Central contacts
Locations
Baylor St. Luke's Medical Center
Recruiting
Houston, Texas, United States, 77030
Contacts
Brian Menegaz
Brian.Menegaz@bcm.eduSponsor
SurgiQuest, Inc.
Last update posted
Jul 9, 2021
Last verified
May, 2021
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by SurgiQuest, Inc. on 2021-07-09.